Patent restraints in certain countries restrict the availability of selected products listed below.
Currently Available Products (Products with US DMF or EDMF available are indicated in blue)
|
Anastrozole |
Galantamine hydrobromide |
|
Azacitidine |
Gemcitabine hydrochloride |
|
Benazepril hydrochloride |
Granisetron hydrochloride |
|
Bimatoprost |
Irinotecan hydrochloride |
|
Bivalirudin |
Letrozole |
|
Capecitabine |
Omeprazole |
|
Cladribine |
Ondansetron hydrochloride |
|
Dantrolene sodium* |
Oxandrolone |
|
Decitabine |
Paclitaxel |
|
Desmopressin acetate |
Pemetrexed
2Na |
|
Docetaxel anhydrous |
Riluzole* |
|
Docetaxel trihydrate |
SN38 |
|
Exemestane |
Tamsulosin hydrochloride |
|
Flavoxate hydrochloride |
Topiramate |
|
Flumazenil |
Topotecan hydrochloride |
|
Fluticasone propionate |
Travoprost |
|
Fulvestrant |
Zoledronic acid |
* Products exclusive in certain areas
Products Under Development
| |
Bortezomib |
Lapatinib |
|
Clofarabine |
Pramlintide acetate |
|
Entecavir |
Sunitinib malate |
| |
Extenatide acetate |
|
| |
|
|
| |
|
|
|
